These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19995813)

  • 1. Neuraminidase inhibitors--the story behind the Cochrane review.
    Doshi P
    BMJ; 2009 Dec; 339():b5164. PubMed ID: 19995813
    [No Abstract]   [Full Text] [Related]  

  • 2. The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.
    Weber JT; Nicoll A; Bridges CB; Ciancio BC
    BMJ; 2010 Jan; 340():c130. PubMed ID: 20071425
    [No Abstract]   [Full Text] [Related]  

  • 3. Oseltamivir resistance: what does it mean clinically?
    Baum SG
    Clin Infect Dis; 2009 Dec; 49(12):1836-7. PubMed ID: 19911972
    [No Abstract]   [Full Text] [Related]  

  • 4. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why don't we have all the evidence on oseltamivir?
    Godlee F; Clarke M
    BMJ; 2009 Dec; 339():b5351. PubMed ID: 19995815
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
    Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
    N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
    [No Abstract]   [Full Text] [Related]  

  • 8. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuraminidase inhibitors and high risk of influenza complications: considered and widely-supported recommendations].
    van Dissel JT; Coutinho RA; van der Sande MA
    Ned Tijdschr Geneeskd; 2009; 153():B486. PubMed ID: 20051160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
    van der Vries E; Stelma FF; Boucher CA
    N Engl J Med; 2010 Sep; 363(14):1381-2. PubMed ID: 20879894
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic.
    Nguyen-Van-Tam JS; Nicholson KG
    J Clin Virol; 2011 Feb; 50(2):183. PubMed ID: 21112812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications: tracking down the data on oseltamivir.
    Cohen D
    BMJ; 2009 Dec; 339():b5387. PubMed ID: 19995818
    [No Abstract]   [Full Text] [Related]  

  • 15. What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?
    Freemantle N; Calvert M
    BMJ; 2009 Dec; 339():b5248. PubMed ID: 19995814
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of neuraminidase inhibitors for severe influenza.
    Fry AM
    Lancet Respir Med; 2014 May; 2(5):346-8. PubMed ID: 24815800
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuraminidase inhibitors for influenza in healthy adults: what we don't know.
    Gupta D; Mootha VK
    Natl Med J India; 2010; 23(1):29-31. PubMed ID: 20839590
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Wolkewitz M; Schumacher M
    Lancet Respir Med; 2014 Jul; 2(7):e8-9. PubMed ID: 24948434
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Leonardi-Bee J; Venkatesan S; Muthuri SG; Nguyen-Van-Tam JS; Myles PR;
    Lancet Respir Med; 2014 Jul; 2(7):e10-2. PubMed ID: 24948433
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Jones M; Del Mar C; Hama R
    Lancet Respir Med; 2014 Jul; 2(7):e9-e10. PubMed ID: 24948431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.